- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Submit a Manuscript
- Subscription Information
- Table of Contents
ISRN Obstetrics and Gynecology
Volume 2012 (2012), Article ID 264918, 6 pages
Diagnosing Arthrogryposis Multiplex Congenita: A Review
Second Department of Obstetrics and Gynecology, Aretaieion University Hospital, University of Athens, 76 Vas. Sofias Avenue, 11528 Athens, Greece
Received 5 August 2012; Accepted 26 August 2012
Academic Editors: K. Chan, N. A. Ginsberg, and M. Khandelwal
Copyright © 2012 Emmanouil Kalampokas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Arthrogryposis multiplex congenita (AMC) refers either to a syndromic or to a nonsyndromic group of conditions with varied etiology and complex clinical features, including multiple congenital contractures in different body areas. Its etiology still remains unclear but generally any cause that leads to reduced fetal movement may lead to congenital contractures and in severe cases to fetal akinesia deformation sequence (FADS). It affects approximately 1 in 2-3000 live births with an approximately equal gender ratio. There are many known subgroups of AMC differing in signs, symptoms, and causes. The primary diagnosis is made when a lack of mobility and an abnormal position is noted in routine ultrasound scanning. Early diagnosis, prenatal evaluation, and further surveillance via image scanning (ultrasound and MRI) give the opportunity for family counseling concerning neonatal morbidity and mortality and labor or delivery planning. Better understanding of the ultrasound findings and the etiology of this clinical situation offers the opportunity for careful prenatal assessment.
Congenital contracture is a muscle condition present from birth and refers to an abnormal and usually permanent contraction of muscle fibers, with a concomitant inability of passive extension and flexion and may be due to prolonged immobilization, serious injuries, and musculoskeletal or circulatory disorders containing isolated contractures and multiple contractures. Approximately 1% of all live births show some type of contractures in one or more joints ranging in severity from unilateral clubfoot to fetal akinesia or the classic Pena-Shokeir phenotype (perinatal lethal form of multiple contracture conditions) .
Arthrogryposis multiplex congenita (AMC) consists of several conditions of different etiology and mixed clinical features, including multiple congenital contractures in multiple body areas. The etiology still remains unclear but generally any cause that leads to reduced fetal movement may guide to congenital contractures and in severe cases to fetal akinesia deformation sequence (FADS) because proper fetal growth is dependent on fetal movement, starting by 8 weeks’ gestation [2, 3]. For practical reasons, it can be divided into subgroups, as a way of generating a differential diagnosis which includes neurological diseases (brain, spine, or peripheral nerve), connective tissue defects (diastrophic dysplasia), muscle abnormalities (muscular dystrophies or mitochondrial abnormalities), space limitations within the uterus (oligohydramnios, fibroids, uterine malformations, or multiple pregnancy), intrauterine or fetal vascular compromise (impaired normal development of nerves, or anterior horn cell death), and maternal diseases (diabetes mellitus, multiple sclerosis, myasthenia gravis, infection, drugs, or trauma) [4–6]. It should be also noted that arthrogryposis could be a clinical manifestation of different syndromes such as dysgenesis of the nervous system observed in chromosome abnormalities (trisomy 18 and 21) and dysplasias of brainstem nuclei and spinal cord as seen in the Möbius, Pierre-Robin, prune belly, and Zellweger syndrome . It affects approximately 1 in 2-3000 live births [2, 8] or 1 in 5–10000 live births according to other authors [9, 10] with an approximately equal gender ratio.
What is more, connective tissue deposition is observed around joints due to intrauterine fetal movement restriction, resulting in fixation and contractures or skeletal abnormalities . The above-mentioned joint abnormalities may involve all limbs (usually) in the lower or the upper extremities. Arthrogryposis is usually symmetrical, but, less frequently, various joints may be involved to a different extent .
2. Arthrogryposis Multiplex Congenital (AMC)
AMC is a rare sporadic nonprogressive congenital disorder that is characterized by multiple joint contractures and can incorporate muscle weakness and fibrosis. The disease name derives from Greek, meaning “curved or hooked joints.” Research has shown that anything that inhibits normal joint movement before birth can result in joint contractures since tendons connecting to the joint are not stretched to their normal length.
In animal models, viruses, neuromuscular diseases, hyperthermia, and limb immobilization are responsible for contractures . In spite of the fact that fetal akinesia in humans is the major cause of AMC, there are multiple and varied intrinsic as well as extrinsic causes for reduced fetal movements. Categorization in groups of causes that are responsible for impaired fetal movement are described by Hall .
2.1.1. Neurologic Abnormalities
Neurologic abnormalities seem to be one of the most common causes of AMC (approximately 70–80% of cases). The reason for this is brain disorders shown by magnetic resonance imaging (MRI), prenatal ultrasound (in order to define intracranial pathology), and later at postpartum autopsies like epilepsy, defects in neural migration, cerebral hypoplasia, holoprosencephaly, pyramidal tract degeneration, and olivoponto-cerebellar degeneration [8, 12–18] which can be associated with chromosomal aneuploidy, an underlying genetic syndrome or the result of a teratogen . Anterior horn cell disease (including the Werdnig-Hoffmann disease) is one of the most common causes of spinal cord degeneration (autosomal inheritance)  with spinal muscular atrophy being a close second neurogenic cause of arthrogryposis [14, 19]. Last but not least, peripheral neuropathy has been closely associated with AMC  because of medium-to-large-axon demyelination as a result of deficiency of the myelin proteins P2 and P0, myelin basic protein, and myelin-associated glycoprotein showing that arrest of peripheral myelination at the promyelin stage appears to be the origin of myelin deficiency . In addition, failure in spinal lengthening and longitudinal growth of Schwann cells could also lead to AMC .
2.1.2. Muscle Abnormalities
To begin with, an association has been strongly linked between AMC and myasthenia mainly because of maternal antibodies entering fetal circulation through transplacental transfer and thus inhibiting fetal acetylcholine receptor function leading to damage to fetal muscle, impaired fetal movement in utero, and the development of multiple joint contractures [23–25]. For example, a large number of neonatal cases in women with myasthenia gravis has been reported with hypotonia, extraocular weakness, bulbar symptoms, respiratory distress, and multiple joint contractures [26–28].
Furthermore, disorders arriving from the muscles like muscular dystrophy, myopathies, myositis, and mitochondrial disorders are common causes of AMC. These include central core disease, nemaline myopathy, intranuclear rod myopathy, and many other types of congenital myopathies [1, 29, 30] caused by a mutation in the gene encoding for sarcomeric thin filament protein troponin I  or a deficiency of -actinin-3 . Congenital muscular dystrophies (1–10000 live births) are the result of abnormal function of the dystrophin-glycoprotein-associated complex in the sarcolemma of skeletal muscles . In addition, mitochondrial cytopathy is also considered to play a major role in AMC . The pathophysiologic mechanism of this is located in the area of muscle fibers (ragged-red fibers), central nervous system, and chondrocytes [34, 35].
2.1.3. Connective Tissue Abnormalities
AMC may also result from connective tissue abnormalities because of a collagenic response (law of connective tissue) on account of the resultant loss of muscle mass with an imbalance of muscle power at the joints. The collagenic response consists of partial replacement of muscle volume and collagenous thickening of the joint capsules leading to joint fixation [36, 37], subsequent reduced fetal movement, and contractures observed in pterygium syndrome [4, 13, 38], congenital contractural arachnodactyly, Beals syndrome (congenital heart disease, scoliosis, arachnodactyly, and “crumpled ears”), and Larsen syndrome (anterior dislocation of the knees) [1, 39].
2.1.4. Intrauterine Space Constraint, Vascular Compromise, Maternal Disease, and Teratogenic Exposure
Amniotic cavity filled with amniotic fluid protects the fetus from extrinsic hazardous factors and provides the adequate space for proper fetal development and movement. Pathologies arriving from the volume of amniotic fluid like oligohydramnios (which commonly results from leakage of amniotic fluid due to cervical incompetence or due to Potter’s syndrome (bilateral renal agenesis)) are some of the major causes of space limitation hence leading to contractures which are more severe the earlier they happen [1, 13, 40, 41]. Furthermore, amniocentesis before 15 weeks of gestation has been reported to have a 10-fold higher risk for multiple contractures and clubfoot . Moreover, this can also be observed in congenital uterine deformities, fibroids, uterine tumors, and multiple pregnancy  (as it is known that incidence of arthrogryposis is more common among twins than singletons ).
Next, inadequate vascular supply to the fetus causes fetal hypoxia that leads to anoxic injury of tissue and/or blood clots or blockage of blood flow resulting in possible cell death, particularly anterior horn cell death or failure. Inferior anterior horn cell function would likely cause fetal neuron, muscle, and bone damage and secondary multiple joint contractures [7, 41]. In addition, maternal disease, such as diabetes mellitus, multiple sclerosis, myotonic dystrophy, and infections (such as rubella, varicella, equine encephalitis, cytomegalovirus, and toxoplasmosis) have been closely related with fetal akinesia and subsequent AMC. However, in many cases this cannot be proved if it was causal rather than coincidental [4, 7, 42–45]. Lastly, medical administration or drug abuse during pregnancy, for instance of curare (a skeletal muscle relaxant), misoprostol, or substances such as cocaine and alcohol, can result in congenital contractures if given at a critical period of fetal development [46, 47].
There are many known subgroups of AMC differing in signs, symptoms, and causes. The principal cause of AMC is both genetic and environmental factors, occurring individually or with a significant overlap among them. In order to establish a differential diagnosis in early child life, it is crucial to determine first if a child has normal neurological function or not. A normal one suggests that arthrogryposis is a result of amyoplasia (the most common recognizable form of AMC which is a sporadic symmetric syndrome that is characterized by the symmetrical improper development of limb muscles which are replaced by fatty and connective tissue and often a midline hemangioma), distal arthrogryposis (an autosomal-dominant inherited syndrome with a characteristic involvement of distal joints with sparing of the large joints; the upper limbs show ulnar deviation, camptodactyly, hypoplastic, or absent flexion and overriding fingers whereas the lower ones can show talipes equinovarus, calcaneovalgus, vertical talus, and metatarsus varus), a systemic connective tissue disorder, multiple pterygium syndromes (a group of autosomal dominant, recessive, or X-linked inherited syndromes manifested with multiple contractures (“pterygia”), micrognathia, low-set ears, cardiac and lung hypoplasia, cystic hygroma, and hydrops), or fetal crowding [1, 11, 39]. On the contrary, an abnormal neurological function highlights that diminished fetal movement in utero was the result of an abnormality of the central or peripheral nervous system, the motor end plate, or the muscles  (Table 1).
2.3. Ultrasound Scanning Findings
Although fetal movement is observed by ultrasound scan at 8 weeks’ gestation, most cases of AMC are diagnosed prenatally at the second or third trimester of pregnancy with ultrasound scan and/or with the combination of maternal consideration for reduced fetal in utero movements. The combination of maternal consideration for fetal akinesia with ultrasound abnormalities (usually before the perception of fetal movement) will give the prospect of an arthrogrypotic syndrome [2, 42, 49]. The earlier the contractures occur (or if there is a syndrome present with abnormalities other than skeletal malformations), the harder early prenatal diagnosis will be .
The primary diagnosis is made when a lack of mobility and an abnormal position is noted in routine ultrasound scanning. These findings should guide the practitioner to a careful assessment of fetal anatomy and joints. The most common detailed ultrasound scan findings are fixed flexion deformities, micrognathia, altered amniotic fluid volume, limb deformities, cerebral ventriculomegaly, dysmorphic features, and growth retardation . AMC may also be present with increased nuchal translucency at 10–14 weeks  or increased nuchal translucency and scoliosis at 15 weeks  of pregnancy due to nuchal edema that has been found in first and early second trimester cases of arthrogryposis [51, 52], cystic hygroma  and fetal seizures  on first trimester ultrasound, small chest, thin ribs, and multiple diaphyseal fractures . Visualization of details of the dynamics of small anatomical structures can now be done better and earlier (body and limb movements can be visualized a week earlier than with 2D) with the use of 4D ultrasound giving the possibility of a diagnosis of motoric failure by the end of the first trimester  (Table 2).
2.4. Signs and Symptoms
Some of the more common signs and symptoms are associated with the shoulder (internal rotation), elbow (extension and pronation), wrist (volar and ulnar), hand (fingers in fixed flexion and thumb in palm), hip (flexed, abducted and externally rotated, often dislocated), knee (flexion), and foot (clubfoot). In some cases, a small number of joints may be affected and may have an almost full range of motion capabillity but in the most severe types, nearly every joint is involved, including the jaw and back [11, 56]. Furthermore, complications may include various congenital anomalies from the organs that can be related with arthrogryposis such as scoliosis, lung hypoplasia, respiratory problems, growth retardation, midfacial hemangioma, facial and jaw variations and abdominal hernias, congenital heart defects, tracheoesophageal fistulas, and ophthalmologic abnormalities  (Table 3).
Multiple contractures in general and AMC more specifically are a common ultrasound finding although they are described as clinical findings rather than a precise diagnosis. Neurogenic, or myopathy disorder, connective tissue process, intrauterine compression, vascular compromise, or teratogenic exposure could be the principal cause of the ultrasound finding .
Early diagnosis, prenatal evaluation, and further surveillance via image scanning (ultrasound and MRI) give the opportunity for family counseling concerning elevated neonatal morbidity and mortality in these cases and labor or delivery planning. Patients should be also informed that a specific prenatal diagnosis of arthrogryposis reaches only up to 50% . Craniofacial abnormalities and micrognathia more often seems to be the consequence of neuromuscular dysfunction because of the adequate growth for the craniofacial bones, fetal muscle movement is required [45, 51].
Diagnosis of the condition by ultrasound will depend on the gestational age and possible presence of other anomalies, with additional MRI surveillance providing additional information such as distal muscle atrophy, abnormal muscle formation, and lung volume measuring [58, 59]. In several previous studies, the focus has been given to cystic hygroma and increased nuchal translucency with combination of reduced fetal movements in utero leading in this way to an early diagnosis of arthrogryposis in first and/or early second trimester of pregnancy [42, 49, 50, 60].
The importance of autopsy and tissue procurement should be noted to parents as it can confirm prenatal diagnosis and provide families with valuable information other than that given by ultrasound and MRI scanning .
Congenital contractures are a common birth defect and a subsequently prenatal ultrasound finding, observed more often randomly in early second trimester ultrasound prenatal assessment. Any factor that predisposes the fetus to impaired fetal movement can cause congenital contractures, such as environmental, maternal, and genetic factors. AMC is a term that describes contractures in multiple joints, in more than one area of the body, associated with fetal morbidity and future economic burden to put right. Better understanding of ultrasound findings and the etiology of this clinical situation offers an opportunity for careful prenatal assessment through thorough image scanning focusing on flexion/extension, position of proximal and distal joints, jaw, and spine. When prenatal diagnosis is suspected families should be counseled for potential postnatal or postterm evaluation.
- B. D. Rink, “Arthrogryposis: a review and approach to prenatal diagnosis,” Obstetrical & Gynecological Survey, vol. 66, no. 6, pp. 369–377, 2011.
- O. B. Navti, E. Kinning, P. Vasudevan et al., “Review of perinatal management of arthrogryposis at a large UK teaching hospital serving a multiethnic population,” Prenatal Diagnosis, vol. 30, no. 1, pp. 49–56, 2010.
- I. Witters, P. Moerman, and J. P. Fryns, “Fetal akinesia deformation sequence: a study of 30 consecutive in utero diagnoses,” American Journal of Medical Genetics, vol. 113, no. 1, pp. 23–28, 2002.
- J. G. Hall, “Arthrogryposis multiplex congenita: etiology, genetics, classification, diagnostic approach, and general aspects,” Journal of Pediatric Orthopaedics Part B, vol. 6, no. 3, pp. 159–166, 1997.
- A. Polizzi, S. M. Huson, and A. Vincent, “Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis,” Teratology, vol. 62, no. 5, pp. 332–341, 2000.
- P. R. J. Barnes, D. J. Kanabar, L. Brueton et al., “Recurrent congenital arthrogryposis leading to a diagnosis of myasthenia gravis in an initially asymptomatic mother,” Neuromuscular Disorders, vol. 5, no. 1, pp. 59–65, 1995.
- N. Gordon, “Arthrogryposis multiplex congenita,” Brain and Development, vol. 20, no. 7, pp. 507–511, 1998.
- J. G. Hall, “Genetic aspects of arthrogryposis,” Clinical Orthopaedics and Related Research, vol. 194, pp. 44–53, 1985.
- N. Darin, E. Kimber, A. K. Kroksmark, and M. Tulinius, “Multiple congenital contractures: birth prevalence, etiology, and outcome,” Journal of Pediatrics, vol. 140, no. 1, pp. 61–67, 2002.
- O. Laitinen and M. Hirvensalo, “Arthrogryposis multiplex congenita,” Annales Paediatriae Fenniae, vol. 12, no. 2, pp. 133–138, 1966.
- W. P. Bevan, J. G. Hall, M. Bamshad, L. T. Staheli, K. M. Jaffe, and K. Song, “Arthrogryposis multiplex congenita (amyoplasia): an orthopaedic perspective,” Journal of Pediatric Orthopaedics, vol. 27, no. 5, pp. 594–600, 2007.
- E. Brodtkorb, T. Torbergsen, K. O. Nakken, K. Andersen, R. Gimse, and O. Sjaastad, “Epileptic seizures, arthrogryposis, and migrational brain disorders: a syndrome?” Acta Neurologica Scandinavica, vol. 90, no. 4, pp. 232–240, 1994.
- K. Vuopala, J. Leisti, and R. Herva, “Lethal arthrogryposis in Finland—a clinico-pathological study of 83 cases during thirteen years,” Neuropediatrics, vol. 25, no. 6, pp. 308–315, 1994.
- E. Fedrizzi, G. Botteon, M. Inverno, E. Ciceri, L. D'Incerti, and F. Dworzak, “Neurogenic arthrogryposis multiplex congenita: clinical and MRI findings,” Pediatric Neurology, vol. 9, no. 5, pp. 343–348, 1993.
- P. Moerman and P. G. Barth, “Olivo-ponto-cerebellar atrophy with muscular atrophy, joint contractures and pulmonary hypoplasia of prenatal onset,” Virchows Archiv, vol. 410, no. 4, pp. 339–345, 1987.
- Y. Fukuyama, M. Osawa, and H. Suzuki, “Congenital progressive muscular dystrophy of the Fukuyama type-clinical, genetic and pathological considerations,” Brain and Development, vol. 3, no. 1, pp. 1–29, 1981.
- G. Hageman and J. Willemse, “Arthrogryposis multiplex congenita. Review with comment,” Neuropediatrics, vol. 14, no. 1, pp. 6–11, 1983.
- V. Laugel, C. Dalloz, E. S. Tobias et al., “Cerebro-oculo-facio-skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation,” Journal of Medical Genetics, vol. 45, no. 9, pp. 564–571, 2008.
- P. M. Bingham, N. Shen, H. Rennert et al., “Arthrogryposis due to infantile neuronal degeneration associated with deletion of the SMN(T) gene,” Neurology, vol. 49, no. 3, pp. 848–851, 1997.
- G. M. Yuill and P. G. Lynch, “Congenital non progressive peripheral neuropathy with arthrogryposis multiplex,” Journal of Neurology Neurosurgery and Psychiatry, vol. 37, no. 3, pp. 316–323, 1974.
- K. B. Boylan, D. M. Ferriero, C. M. Greco, R. A. Sheldon, and M. Dew, “Congenital hypomyelination neuropathy with arthrogryposis multiplex congenita,” Annals of Neurology, vol. 31, no. 3, pp. 337–340, 1992.
- L. Charnas, B. Trapp, and J. Griffin, “Congenital absence of peripheral myelin: abnormal Schwann cell development causes lethal arthrogryposis multiplex congenita,” Neurology, vol. 38, no. 6, pp. 966–974, 1988.
- J. Reimann, L. Jacobson, A. Vincent, and C. Kornblum, “Endplate destruction due to maternal antibodies in arthrogryposis multiplex congenita,” Neurology, vol. 73, no. 21, pp. 1806–1808, 2009.
- P. Dalton, L. Clover, R. Wallerstein et al., “Fetal arthrogryposis and maternal serum antibodies,” Neuromuscular Disorders, vol. 16, no. 8, pp. 481–491, 2006.
- A. Vincent, L. Jacobson, P. Plested et al., “Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenita,” Annals of the New York Academy of Sciences, vol. 841, pp. 482–496, 1998.
- J. Vajsar, A. Sloane, D. L. MacGregor, G. M. Ronen, L. E. Becker, and V. Jay, “Arthrogryposis multiplex congenita due to congenital myasthenic syndrome,” Pediatric Neurology, vol. 12, no. 3, pp. 237–241, 1995.
- J. T. Chieza, I. Fleming, N. Parry, and V. A. Skelton, “Maternal myasthenia gravis complicated by fetal arthrogryposis multiplex congenita,” International Journal of Obstetric Anesthesia, vol. 20, no. 1, pp. 79–82, 2011.
- J. M. Hoff, A. K. Daltveit, and N. E. Gilhus, “Artrogryposis multiplex congenita—a rare fetal condition caused by maternal myasthenia gravis,” Acta Neurologica Scandinavica, vol. 113, supplement 183, pp. 26–27, 2006.
- B. H. F. Sombekke, W. M. Molenaar, A. J. Van Essen, and C. J. F. Schoots, “Lethal congenital muscular dystrophy with arthrogryposis multiplex congenita: three new cases and review of the literature,” Pediatric Pathology, vol. 14, no. 2, pp. 277–285, 1994.
- M. Z. Seidahmed, Y. Sunada, C. O. Ozo, F. Hamid, K. R. Campbell, and M. A. M. Salih, “Lethal congenital muscular dystrophy in two sibs with arthrogryposis multiplex: new entity or variant of cobblestone lissencephaly syndrome?” Neuropediatrics, vol. 27, no. 6, pp. 305–310, 1996.
- E. Kimber, H. Tajsharghi, A. K. Kroksmark, A. Oldfors, and M. Tulinius, “A mutation in the fast skeletal muscle troponin I gene causes myopathy and distal arthrogryposis,” Neurology, vol. 67, no. 4, pp. 597–601, 2006.
- K. N. North and A. H. Beggs, “Deficiency of a skeletal muscle isoform of α-actinin (α-actinin-3) in merosin-positive congenital muscular dystrophy,” Neuromuscular Disorders, vol. 6, no. 4, pp. 229–235, 1996.
- E. McPherson and C. Zabel, “Mitochondrial mutation in a child with distal arthrogryposis,” American Journal of Medical Genetics, vol. 140, no. 2, pp. 184–185, 2006.
- B. Laubscher, R. C. Janzer, S. Krähenbühl, L. Hirt, and T. Deonna, “Ragged-red fibers and complex I deficiency in a neonate with arthrogryposis congenita,” Pediatric Neurology, vol. 17, no. 3, pp. 249–251, 1997.
- H. Nogami, N. Ogasawara, and T. Kasai, “Lipid storage myopathy associated with scoliosis and multiple joint contractures,” Acta Neuropathologica, vol. 61, no. 3-4, pp. 305–310, 1983.
- F. Bonilla-Musoles, L. E. Machado, and N. G. Osborne, “Multiple congenital contractures (congenital multiple arthrogryposis),” Journal of Perinatal Medicine, vol. 30, no. 1, pp. 99–104, 2002.
- C. A. Swinyard and E. E. Bleck, “The etiology of arthrogryposis (multiple congenital contracture),” Clinical Orthopaedics and Related Research, vol. 194, pp. 15–29, 1985.
- S. Y. Parashar, P. J. Anderson, N. McLean, M. Djohansjah, and D. J. David, “Spectrum of features in pterygium syndrome,” Asian Journal of Surgery, vol. 29, no. 2, pp. 104–108, 2006.
- M. Bamshad, L. B. Jorde, and J. C. Carey, “A revised and extended classification of the distal arthrogryposes,” American Journal of Medical Genetics, vol. 65, no. 4, pp. 277–281, 1996.
- S. Martin and J. D. Tobias, “Perioperative care of the child with arthrogryposis,” Paediatric Anaesthesia, vol. 16, no. 1, pp. 31–37, 2006.
- J. G. Hall, “Arthrogryposis associated with unsuccessful attempts at termination of pregnancy,” American Journal of Medical Genetics, vol. 63, no. 1, pp. 293–300, 1996.
- H. Scott, A. Hunter, and B. Bedard, “Non-lethal arthrogryposis multiplex congenita presenting with cystic hygroma at 13 weeks gestational age,” Prenatal Diagnosis, vol. 19, no. 10, pp. 966–971, 1999.
- D. Goksen, S. Darcan, M. Coker et al., “Permanent neonatal diabetes with arthrogryposis multiplex congenita and neurogenic bladder-a new syndrome?” Pediatric Diabetes, vol. 7, no. 5, pp. 279–283, 2006.
- I. R. Livingstone and G. H. Sack Jr, “Arthrogryposis multiplex congenita occurring with maternal multiple sclerosis,” Archives of Neurology, vol. 41, no. 11, pp. 1216–1217, 1984.
- H. J. Porter, “Lethal arthrogryposis multiplex congenita (fetal akinesia deformation sequence, fads),” Pediatric Pathology and Laboratory Medicine, vol. 15, no. 4, pp. 617–637, 1995.
- E. Hammond and A. E. Donnenfeld, “Fetal akinesia,” Obstetrical and Gynecological Survey, vol. 50, no. 3, pp. 240–249, 1995.
- K. E. Coelho, M. F. Sarmento, C. M. Veiga, et al., “Misoprostol embryotoxicity: clinical evaluation of fifteen patients with arthrogryposis,” American Journal of Medical Genetics, vol. 95, no. 4, pp. 297–301, 2000.
- M. Bamshad, A. E. Van Heest, and D. Pleasure, “Arthrogryposis: a review and update,” Journal of Bone and Joint Surgery A, vol. 91, supplement 4, pp. 40–46, 2009.
- J. Hyett, P. Noble, N. J. Sebire, R. Snijders, and K. H. Nicolaides, “Lethal congenital arthrogryposis presents with increased nuchal translucency at 10-14 weeks of gestation,” Ultrasound in Obstetrics and Gynecology, vol. 9, no. 5, pp. 310–313, 1997.
- R. Madazli, B. Tüysüz, F. Aksoy, M. Barbaros, S. Uludaǧ, and V. Ocak, “Prenatal diagnosis of arthrogryposis multiplex congenita with increased nuchal translucency but without any underlying fetal neurogenic or myogenic pathology,” Fetal Diagnosis and Therapy, vol. 17, no. 1, pp. 29–33, 2002.
- J. G. Hall, “Analysis of Pena Shokeir phenotype,” American Journal of Medical Genetics, vol. 25, no. 1, pp. 99–117, 1986.
- C. M. Quinn, J. S. Wigglesworth, and J. Heckmatt, “Lethal arthrogryposis multiplex congenita: a pathological study of 21 cases,” Histopathology, vol. 19, no. 2, pp. 155–162, 1991.
- B. Sheizaf, M. Mazor, D. Landau, E. Burstein, A. Bashiri, and R. Hershkovitz, “Early sonographic prenatal diagnosis of seizures,” Ultrasound in Obstetrics and Gynecology, vol. 30, no. 7, pp. 1007–1009, 2007.
- H. Chen, W. R. Blackburn, and W. Wertelecki, “Fetal akinesia and multiple perinatal fractures,” American Journal of Medical Genetics, vol. 55, no. 4, pp. 472–477, 1995.
- A. Kurjak, N. Vecek, T. Hafner, T. Bozek, B. Funduk-Kurjak, and B. Ujevic, “Prenatal diagnosis: what does four-dimensional ultrasound add?” Journal of Perinatal Medicine, vol. 30, no. 1, pp. 57–62, 2002.
- B. Steinberg, V. S. Nelson, S. E. Feinberg, and C. Calhoun, “Incidence of maxillofacial involvement in arthrogryposis multiplex congenita,” Journal of Oral and Maxillofacial Surgery, vol. 54, no. 8, pp. 956–959, 1996.
- J. G. Brooks Jr and D. J. Coster, “Arthrogryposis multiplex congenita: a report of two cases,” Australian and New Zealand Journal of Ophthalmology, vol. 22, no. 2, pp. 127–132, 1994.
- J. Philpot, S. Counsell, G. Bydder, C. A. Sewry, V. Dubowitz, and F. Muntoni, “Neonatal arthrogryposis and absent limb muscles: a muscle developmental gene defect?” Neuromuscular Disorders, vol. 11, no. 5, pp. 489–493, 2001.
- E. U. Senocak, K. K. Oguz, G. Haliloglu, D. Karcaaltincaba, D. Akata, and O. Kandemir, “Prenatal diagnosis of Pena-Shokeir syndrome phenotype by ultrasonography and MR imaging,” Pediatric Radiology, vol. 39, no. 4, pp. 377–380, 2009.
- B. J. Baty, D. Cubberley, C. Morris, and J. Carey, “Prenatal diagnosis of distal arthrogryposis,” American Journal of Medical Genetics, vol. 29, no. 3, pp. 501–510, 1988.
- R. Herva, J. Leisti, P. Kirkinen, and U. Seppanen, “A lethal autosomal recessive syndrome of multiple congenital contractures,” American Journal of Medical Genetics, vol. 20, no. 3, pp. 431–439, 1985.
- P. A. Boyd, F. Tondi, N. R. Hicks, and P. F. Chamberlain, “Autopsy after termination of pregnancy for fetal anomaly: retrospective cohort study,” British Medical Journal, vol. 328, no. 7432, pp. 137–140, 2004.